19480611

Source:http://linkedlifedata.com/resource/pubmed/id/19480611

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0010181, umls-concept:C0017504, umls-concept:C0021294, umls-concept:C0035236, umls-concept:C0199176, umls-concept:C0439230, umls-concept:C0672596, umls-concept:C0936012, umls-concept:C0947611
pubmed:issue	7
pubmed:dateCreated	2009-6-24
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0351014
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Respiratory Syncytial Virus Vaccines, http://linkedlifedata.com/resource/pubmed/chemical/palivizumab
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1473-4877
pubmed:author	pubmed-author:RobinsonJoan LJL
pubmed:issnType	Electronic
pubmed:volume	25
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1631-2; author reply 1632-3
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:19480611-Antibodies, Monoclonal, pubmed-meshheading:19480611-Antibodies, Monoclonal, Humanized, pubmed-meshheading:19480611-Canada, pubmed-meshheading:19480611-Cohort Studies, pubmed-meshheading:19480611-Cost-Benefit Analysis, pubmed-meshheading:19480611-Gestational Age, pubmed-meshheading:19480611-Humans, pubmed-meshheading:19480611-Infant, Newborn, pubmed-meshheading:19480611-Infant, Premature, pubmed-meshheading:19480611-Respiratory Syncytial Virus Infections, pubmed-meshheading:19480611-Respiratory Syncytial Virus Vaccines
pubmed:year	2009
pubmed:articleTitle	Comment and reply on: The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: a Canadian-based analysis.
pubmed:publicationType	Letter, Evaluation Studies